newsfilter
← Latest News
GlobeNewswire·

VectivBio Announces Closing of $54 Million Aggregate Financing

BASEL, Switzerland, June 29, 2022 (GLOBE NEWSWIRE) -- VectivBio Holding AG ("VectivBio") (NASDAQ:VECT), a clinical-stage biopharmaceutical company pioneering novel transformational treatments for severe rare conditions, announces it has closed each of